Hematology and Medical Oncology Grand Rounds
September - June (on hiatus during summer months)
The Hematology/Oncology conferences listed on this page are only open to Larner, UVM, and UVM Health students and employees.
Upcoming Hematology/Oncology Grand Rounds
Recent Grand Rounds Presentations
Academic Year 2026 - 2027
| Speaker | Affiliation | Presentation |
|---|---|---|
| Dermot Murphy, MD, MB BS | Third Year Physician Fellow in Hematology and Medical Oncology, UVM Health | Delay in Diagnosis: Morbidity and Morality Conference |
| Elsy Rivera, MD | Third Year Physician Fellow in Hematology and Medical Oncology, UVM Health | Beyond the Pain Crisis: From Vaso-Occlusion to Chronic Pain in Sickle Cell Disease |
| Jaina Clough, MD | Hospice and Palliative Medicine, UVM Health - UVM Medical Center & UVM Home Health & Hospice | ACT 39: Medical Aid in Dying in Vermont (Clinical Review) |
| Duaa Kanan, MD | Second Year Physician Fellow in Hematology and Medical Oncology, UVM Health | Current and Novel Applications of Therapeutic Plasma Exchange in Hematology and Oncology |
| Megan Tesch, MD, MPH | Medical Breast Oncologist, Dana Farber Cancer Institute and Instructor in Medicine, Harvard Medical School | Early Onset Breast Cancer: Interplay Between Tumor Biology and Host Factors |
| Sarah Gillett, MD, PhD | Hematology and Oncology, UVM Health/Larner College of Medicine | Breaking the RAS Barrier: The KRAS Revolution in Pancreatic Cancer: From "undruggable" oncogene to first approved targeted therapy in PDAC |
| Meredith Ryan, MD | Second Year Fellow in Hematology and Medical Oncology, UVM Health | Learning Oncology in 2026 |
Academic Year 2025 - 2026
| Speaker | Affiliation | Grand Rounds Presentation |
|---|---|---|
| Dr. Sienna Searles | First Year Physician Fellow in Hematology and Medical Oncology, UVM Health | The Effects of Plastic Exposure on Human Health: An Introduction and Review |
| Dr. Elsy Rivera | Second Year Physician Fellow in Hematology and Medical Oncology, UVM Health | Fatal Rhino-Orbital-Cerebral Mucormycosis in a Post-Transplant AML Patient |
| Alexander Boucher, MD | Pediatric Hematology/Oncology; Medicine-Hematology, Oncology, and Transplantation, University of Minnesota | Sickle Call Disease Care: Harnessing the Headwinds |
| Meredith Ryan, MD | Second Year Physician Fellow in Hematology and Medical Oncology, UVM Health | Germline Testing in Myeloid Malignancies |
| Shruti Khurana, MD | Medicine - Gastroenterology/UVM Health Chron's and Colitis Center | Cellular Therapies for Inflammatory Bowel Disease: An IBD Specialist's Perspective |
| Elsy Rivera, MD | Second Year Physician Fellow in Hematology and Medical Oncology, UVM Health | De-Mystifying Systems Hematology |
| Dermot Murphy, MD, MB BS | Second Year Physician Fellow in Hematology and Medical Oncology, UVM Health | Clonal Hematopoiesis: Causes and Consequences |
| Jinah Kim, MD | Third Year Physician Fellow in Hematology and Medical Oncology, UVM Health | GLP-1 Receptor Agonists: An Oncology Perspective |
| Jacqueline Poston, MD | Pathology and Laboratory Medicine; Hematology and Oncology, Larner College of Medicine and UVM Health | Transfusion Challenges and Opportunities for Hematologic Malignancies in 2026 |
| Chris Holmes, MD, PhD | Division Chief, Hematology and Oncology, UVM LCOM/UVM Health | Integrating Biology, Clinical Trials, and Implementation Science to Prevent Thrombotic Complications in Patients with Cancer |
| Ike Chidobem, MD | Third Year Physician Fellow in Hematology and Medical Oncology, UVM Health | Morbidity and Mortality Conference |
| Duaa Kanan, MD | First Year Physician Fellow in Hematology and Medical Oncology, UVM Health | A Focus on Cancer Prevention and Molecular Oncology |
| Deena Snoke, PhD | Post-Doctoral Research Associate, Toth Laboratory, Department of Medicine - Pulmonary and Critical Care | Temporal variation in body composition during the lung cancer continuum |
| Jinah Kim, MD | Third Year Fellow in Hematology and Medical Oncology, UVM Health | Fellows Conference/Morbidity & Mortality Conference: Fatal Outcome After CAR-T Complicated by CRS/ICANS |
| Jay Raval, MD | Pathology and Laboratory Medicine, Larner College of Medicine and UVM Health | Therapeutic Plasma Exchange: Updates in Evidence for Practice Patterns in Procedure Performance |
| Dermot Murphy, MD, MB BS | Second Year Fellow in Hematology and Medical Oncology, UVM Health | Fellows Conference: "Recent Developments in Mantle Cell Lymphoma" |
| Michael Kroll, MD | Emeritus, MD Anderson Cancer Center, University of Texas | Hematologic Complications of Checkpoint Inhibitors |
Marlise Luskin, MD
| Dana Farber Cancer Institute | Ph+ ALL: Progress and Prospects
|
Academic Year 2024-2025
For prior years Grand Rounds schedule please contact Whitney Feininger
| Speaker | Affiliation | Presentation |
|---|---|---|
David Iberri, MD
| Stanford University | How I avoid overtreating myeloma: Musings of a west coast myeloma doctor
|
| Jonathan Boyson, PhD | University of Vermont | Emerging roles of gamma delta T cells in cancer
|
| Elizabeth Buchbinder | Dana Farber Cancer Institute | What's new in melanoma and what we do when standard therapies fail
|
| Marco Ruella, MD | Penn Medicine | Catch me if you can: Resistance to CAR-T immunotherapy
|
Adam Cuker, MD
| Penn Medicine | Diagnosis and Management of Heparin-Induced Thrombocytopenia: An updated based on the ASH Guidelines
|
| Huntsman Cancer Institute | The New Frontier of Multiple Myeloma |
Jennifer Kelly, MD
| University of Vermont | Bone health management in patients undergoing treatment for malignancy |
Ryan Thomas, MD
| University of Vermont | Morbidity and Mortality Conference |
Maija Reblin, PhD
| University of Vermont | Caregiver Needs in Vermont |
Elsy Rivera, MD
| University of Vermont | Anticoagulant & Antithrombotic Herbs |
Rahul Vedula, MD
| Dana Farber Cancer Institute | "CRISPR-based rapid diagnostics for fusion driven leukemias" |
| Jinah Kim, MD | University of Vermont | The immunotherapy in early triple-negative breast cancer |
Haze Xu, MD
| University of Vermont | Rethinking the Obesity Paradox: Immune Checkpoint Inhibitor and The New Frontier |
| University of Vermont | "Parenthood on Ice: Safeguarding Reproductive Potential During Gonadotoxic Therapy" |
| University of Vermont (Murphy) Dana Farber (Kim) | Morbidity and Mortality Conference |
| Shruti Khurana, MD | Immune Checkpoint Inhibitor Colitis | |
| Dr. Ike Chidobem, 2nd Year Fellow in Hematology and Medical Oncology, UVM Health Network | Bruton's Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukemia (CLL) | |
| Dr. Ryan Thomas, 3rd Year Fellow in Hematology and Medical Oncology, UVM Health Network | Quality Improvement Projects | |
| Dr. Jacqueline Poston, UVM Department of Pathology and Laboratory Medicine | Revolutionizing Care: The Management of Acquired Hemophilia A in 2025 | |
| Dr. Jinah Kim, 2nd Year Fellow in Hematology and Medical Oncology, UVM Health Network | Morbidity and Mortality Conference: A Fatal Opportunistic Infection: Mucormycosis | |
| Dr. Radhika Gangaraju, University of Alabama - Birmingham | Thrombosis in Hematologic Malignancies: Risk Factors and Emerging Biomarkers | |
| Dr. Ike Chidobem, 2nd Year Fellow in Hematology and Medical Oncology, UVM Health Network | Adjuvant CDK 4/6 Inhibitors in HR+/HER2-Breast Cancer |